Literature DB >> 15901990

Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.

J Y Park1, L Chen, A Elahi, P Lazarus, M S Tockman.   

Abstract

The human microsomal epoxide hydrolase (EH) gene contains polymorphic alleles, which may be linked to increased risk for tobacco-related lung cancer. The purpose of this study is to screen new polymorphisms and determine whether these polymorphisms can be used to predict individual susceptibility to lung cancer. The polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis was used to screen for polymorphisms in the coding region of the EH gene. Eleven polymorphisms, including previously reported polymorphisms, were identified and the prevalence of these variants was assessed in at least 50 healthy Caucasians and African-Americans. Among the 11 polymorphisms, the prevalence of the amino acid-changing EH polymorphisms in codons 43, 113 and 139 was examined in 182 Caucasian incident cases with primary lung cancer, as well as in 365 frequency-matched controls to examine the role of EH polymorphisms in lung cancer risk. A significant increase in lung cancer risk was observed for predicted high EH activity genotypes (odds ratio (OR) 2.3, 95% confidence interval (CI) 1.2-4.3) as compared with low EH activity genotypes. This association was more pronounced among patients with lung adenocarcinoma (OR 4.7, 95% CI 1.7-13.1). These results suggest that the EH polymorphism plays an important role in lung cancer risk and is linked to tobacco smoke exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901990      PMCID: PMC3715303          DOI: 10.1097/00008469-200506000-00005

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  38 in total

1.  Susceptibility genes for rapid decline of lung function in the lung health study.

Authors:  A J Sandford; T Chagani; T D Weir; J E Connett; N R Anthonisen; P D Paré
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans.

Authors:  X Wu; K Gwyn; C I Amos; N Makan; W K Hong; M R Spitz
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

Review 3.  Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer.

Authors:  P Lazarus; J Y Park
Journal:  Oral Oncol       Date:  2000-09       Impact factor: 5.337

4.  The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.

Authors:  W Zhou; S W Thurston; G Liu; L L Xu; D P Miller; J C Wain; T J Lynch; L Su; D C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

5.  Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.

Authors:  S J London; J Smart; A K Daly
Journal:  Lung Cancer       Date:  2000-05       Impact factor: 5.705

6.  Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.

Authors:  L Yin; Y Pu; T Y Liu; Y H Tung; K W Chen; P Lin
Journal:  Lung Cancer       Date:  2001 Aug-Sep       Impact factor: 5.705

7.  High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.

Authors:  N Jourenkova-Mironova; K Mitrunen; C Bouchardy; P Dayer; S Benhamou; A Hirvonen
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

8.  Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.

Authors:  J M Lancaster; H A Brownlee; D A Bell; P A Futreal; J R Marks; A Berchuck; R W Wiseman; J A Taylor
Journal:  Mol Carcinog       Date:  1996-11       Impact factor: 4.784

9.  Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians.

Authors:  L Y Park; J E Muscat; T Kaur; S P Schantz; J C Stern; J P Richie; P Lazarus
Journal:  Pharmacogenetics       Date:  2000-03

10.  Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma.

Authors:  P Lin; S L Wang; H J Wang; K W Chen; H S Lee; K J Tsai; C Y Chen; H Lee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  12 in total

1.  Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.

Authors:  Mona Fathy; Mai Hamed; Omnia Youssif; Nahla Fawzy; Wafa Ashour
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

Review 3.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Authors:  Siwen Wang; Jie Zhu; Ruxin Zhang; Siyang Wang; Zongheng Gu
Journal:  Tumour Biol       Date:  2013-02-03

Review 4.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.

Authors:  Ann G Schwartz; John C Ruckdeschel
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

5.  Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.

Authors:  Emily J Boldry; Yesha M Patel; Srikanth Kotapati; Amanda Esades; Sungshim L Park; Maarit Tiirikainen; Daniel O Stram; Loïc Le Marchand; Natalia Tretyakova
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-03-14       Impact factor: 4.254

6.  Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD.

Authors:  Jong Y Park; Lan Chen; Nina Wadhwa; Melvyn S Tockman
Journal:  Int J Mol Med       Date:  2005-03       Impact factor: 4.101

Review 7.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

Review 8.  Review of studies on metabolic genes and cancer in populations of African descent.

Authors:  Camille C Ragin; Scott Langevin; Scott Rubin; Emanuela Taioli
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

9.  Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.

Authors:  Xiang Li; Zheng Hu; Xinshun Qu; Jiadong Zhu; Lin Li; Brian Z Ring; Li Su
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 10.  Regulation of cardiovascular biology by microsomal epoxide hydrolase.

Authors:  Matthew L Edin; Darryl C Zeldin
Journal:  Toxicol Res       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.